CBD and Seizures: New Clinical Evidence Challenges Common Beliefs

CBD and Seizures: New Clinical Evidence Challenges Common Beliefs   Introduction CBD and seizures research has skyrocketed in recent years, challenging traditional treatment paradigms for refractory epilepsy. Epilepsy affects approximately 50 million people globally, according to the World Health Organization (WHO). This neurological disorder, previously limited

Can MRI Detect Old Strokes? New Findings on Silent Brain Infarcts

Can MRI Detect Old Strokes? New Findings on Silent Brain Infarcts   Introduction The question of whether an old stroke appears on magnetic resonance imaging (MRI) holds remarkable clinical importance, particularly in the context of silent brain infarcts (SBIs). These lesions, often asymptomatic, are increasingly recognized as markers

Neuromodulation for Chronic Pain: Breaking Traditional Treatment Boundaries

Neuromodulation for Chronic Pain: Breaking Traditional Treatment Boundaries   Introduction Epilepsy affects more than 70 million individuals worldwide, and approximately 30 percent of patients experience resistance to conventional medical therapy. This subset of patients with drug-resistant or intractable epilepsy often faces major challenges, including reduced quality of

Are We Over-Scanning? The Truth About CT Scans in Minor Head Injury Cases

Are We Over-Scanning? The Truth About CT Scans in Minor Head Injury Cases   Introduction Computed tomography (CT) has become an essential tool in the evaluation of head injuries in emergency departments across the world. Its speed and accuracy in detecting intracranial hemorrhage, skull fractures, and other

Post Surgery Brain Fog: New Evidence Questions Long-Term Safety of Anesthesia

Post Surgery Brain Fog: New Evidence Questions Long-Term Safety of Anesthesia   Introduction Post-surgical brain fog represents a significant and under-recognized complication of anesthesia and surgery, affecting a substantial proportion of patients. Perioperative neurocognitive disorders (PND), which encompass postoperative delirium and longer-term cognitive decline, are

New Alzheimer’s Treatment Targets

Beyond Amyloid: New Alzheimer's Treatment Targets Alternative Brain Pathways   Introduction Alzheimer's disease, the most common cause of dementia accounting for 60-70% of all cases, requires new Alzheimer's treatment approaches as current strategies show limited efficacy. According to the World Health Organization's 2022 blueprint for

How Diet and Exercises Prevent Dementia Through Gut-Brain Pathways

New Evidence: How Diet and Exercises Prevent Dementia Through Gut-Brain Pathways  Please like and subscribe if you enjoyed this video :-)   Introduction Dementia affects approximately 57 million adults worldwide, with Alzheimer's disease accounting for 60-80% of cases. Recent research reveals that

Biomarkers for Alzheimer’s Disease: PET to Plasma

Biomarkers for Alzheimer’s Disease: PET to Plasma  Abstract Background:The diagnostic landscape of Alzheimer’s disease (AD) has shifted considerably in recent years. Traditional diagnosis relied heavily on clinical assessments supported by neuropsychological testing and structural imaging. These approaches, while valuable, often lacked the sensitivity and specificity needed to

Ketogenic Diets in Neurology and Endocrinology: Friend or Fad?

Ketogenic Diets in Neurology and Endocrinology: Friend or Fad?  Abstract The ketogenic diet (KD), defined by a high fat, moderate protein, and very low carbohydrate composition, has undergone a notable resurgence in both clinical practice and popular health discourse. Initially introduced in the 1920s as

Neurocysticercosis: The Hidden Brain Parasite Crossing Global Borders in 2025

Neurocysticercosis: The Hidden Brain Parasite Crossing Global Borders in 2025   Introduction Neurocysticercosis remains the most prevalent parasitic infection of the human central nervous system (CNS) and continues to represent a major global health challenge. Current estimates suggest that more than 50 million individuals

CBD and Seizures: New Clinical Evidence Challenges Common Beliefs